Nuvation Bio Inc. (NUVB)
NYSE: NUVB
· Real-Time Price · USD
3.28
0.01 (0.31%)
At close: Sep 17, 2025, 3:59 PM
3.35
2.13%
Pre-market: Sep 18, 2025, 04:16 AM EDT
0.31% (1D)
| Bid | 3.25 |
| Market Cap | 1.12B |
| Revenue (ttm) | 14.36M |
| Net Income (ttm) | -202.9M |
| EPS (ttm) | -0.38 |
| PE Ratio (ttm) | -8.63 |
| Forward PE | -5.81 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.39 |
| Volume | 4,651,468 |
| Avg. Volume (20D) | 6,161,138 |
| Open | 3.23 |
| Previous Close | 3.27 |
| Day's Range | 3.21 - 3.40 |
| 52-Week Range | 1.54 - 4.09 |
| Beta | 1.37 |
| Ex-Dividend Date | n/a |
About NUVB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NUVB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NUVB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNuvation Bio Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
8 months ago
+14.44%
Nuvation Bio shares are trading higher after RBC C...
Unlock content with
Pro Subscription
